Jupiter Neurosciences shares are trading higher after the company announced it signed a definitive license agreement with PharmAla Biotech Holdings for perpetual exclusive U.S. rights to ALA-002.

8-K filing — JUPITER NEUROSCIENCES, INC. (JUNS)

Filed: 2026-08-27 AccNo: 0001493152-26-040308 Size: 323 KB Item 1.01: Entry into a Material Definitive Agreement Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers Picard Medical (AMEX:PMI) shares moved upwards by 82.7% to $9.38 during Tuesday's regular session. The market value of their outstanding shares is at $10.5 million. As per the news, the Q2 earnings report

12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers Picard Medical (AMEX:PMI) shares moved upwards by 34.6% to $4.32 during Monday's pre-market session. The company's market cap stands at $6.5 million. As per the press release, Q2 earnings came out 3

Jupiter Neurosciences Shares Halted On Circuit Breaker To The Downside, Stock Now Up 43.52%